Where does Aptinyx Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aptinyx Inc. ranks #10,854 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aptinyx Inc. hold?

Aptinyx Inc. holds 28 US utility patents granted between 2016 and 2023, spanning 5 technology areas.

What is Aptinyx Inc.'s Innovation Score?

Aptinyx Inc. has an Innovation Score of 34.0 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Aptinyx Inc. focus on?

Aptinyx Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 28 patents, ranking #708 of 6,058 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Aptinyx Inc.'s patent grant rate increasing or decreasing?

Aptinyx Inc.'s recent grant velocity is -35% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Aptinyx Inc.'s patents?

Aptinyx Inc.'s patents average 17.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aptinyx Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Aptinyx Inc.

USPTO PatentsView assignee record - 28 granted patents across 5 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aptinyx ranks #10,854 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 5 technology areas.

#10,854
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (34.0/100): 17.0
avg claims per patent: -35%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10854 · US Corporation #10,854 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #10,854/49,997
PHOTO-FINISH Americorp Investments
CPC-NARROW A61P · 5 areas
INNOV-THIN 34.0/100
CLAIMS-RICH 17.0 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -35% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Americorp Investments LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aptinyx’s 34.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (34%) Velocity 4.2 pts (12%) Breadth 7.9 pts (23%) Claim depth 10.2 pts (30%)

Qualcomm Incorporated · highest

85
Aptinyx · this assignee

34
e-AAM Driveline… · near

34
NovoBiotic Pharmaceu… · near

34
Coretech System · near

34
Fosbel · near

34
3D Lighting… · lowest

7

What this shows Aptinyx's Innovation Score is 34.0/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aptinyx?

Each dot is one of Aptinyx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aptinyx’s own 17.0 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Aptinyx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aptinyx's grants concentrate

Aptinyx Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (7 grants) versus a trough of 1 in 2023. By volume, Aptinyx sits between Americorp Investments LLC and Atlas Copco Rock Drills AB.

Aptinyx's three-year grant acceleration

Aptinyx Inc. shows 7 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Americorp Investm…

28
Amphenol Commerci…

28
Anapass

28
Apothecary Produc…

28
Ariad Pharmaceuti…

28
Aspen Technology

28
Atlas Copco IAS UK

28
Atlas Copco Rock…

28
Aptinyx ◀

28

What this shows Aptinyx holds 28 patents at rank #10,858, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aptinyx

By rank, the assignees closest to #10,858 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Aptinyx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Aptinyx, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Aptinyx ranks #708 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

e-AAM Driveline Systems AB 34 NovoBiotic Pharmaceuticals, LLC 34 Fosbel, Inc. 34 Coretech System Co., Ltd. 34

Aptinyx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Aptinyx Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	7.1%
2017	4	14.3%
2018	4	14.3%
2019	7	25.0%
2021	4	14.3%
2022	6	21.4%
2023	1	3.6%

Which technologies does Aptinyx Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 28

C07D - Heterocyclic Compounds 28

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 16

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 7

C07K - Peptides 2

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aptinyx Inc.'s patent record in context - here's where to go next.

Aptinyx Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,854 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aptinyx Inc. against Americorp Investments LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.